Contact Information: Media Contact: Amy Cook 925.552.7893 Email Contact
Carl Zeiss Meditec, Inc. Ships Its 500th VISUCAM PRO NM System in the United States
Camera Increases Quality and Simplicity of Fundus Imaging
| Source: Carl Zeiss Meditec, Inc.
DUBLIN, CA -- (MARKET WIRE) -- May 7, 2007 -- Carl Zeiss Meditec, Inc. today announced
installation of its 500th VISUCAM PRO NM non-mydriatic fundus camera at the
Indiana University School of Optometry's Indianapolis Eye Care Center.
Designed for routine clinical use, the compact VISUCAM PRO NM offers
clinicians enhanced fundus visualization and documentation, and is credited
for setting the standard in non-mydriatic ophthalmic photography.
"We are extremely happy with our new VISUCAM and find the camera to be very
user friendly with superb image quality," said Brad Sutton, O.D., F.A.A.O.,
associate professor, Indiana University School of Optometry and clinic
director for the Indianapolis Eye Care Center. "The camera's ability to
obtain high quality images through small pupils enhances fundus
visualization, and its ability to digitally separate images into their red,
green and blue components is very helpful in imaging certain pathologies.
"Additionally, the camera has proven to be an invaluable education tool for
both our interns in training, as well as for our patients," continued Dr.
Sutton.
The VISUCAM PRO NM, which was introduced in June 2005, is designed for
routine clinical use by integrating all the elements of retinal photography
from image capture to documentation. As a result, the camera optimizes
practice efficiency. Visual overview and assessment are possible during
review of the photos for in-depth study because once the image is captured,
brilliant fundus photos immediately appear on the flat-screen monitor and
are automatically stored. Additionally, images are correctly illuminated
regardless of the pupil size and fundus color, allowing for accurate image
comparison and review, as well as quick image transfer via network, USB
stick or DVD.
Clinicians report that the VISUCAM PRO NM has helped to enhance fundus
visualization and documentation for their practice, and as a result,
significantly improve workflow as well as patient comfort due to shortened,
improved exams.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG (ISIN: DE 0005313704) is one of the world's leading
medical technology companies. This market position is based on over 160
years of experience in optical innovation. The company has two primary
areas of activitiy. In the field of ophthalmology, Carl Zeiss Meditec
offers integrated solutions for treating the four main eye diseases: vision
defects (refraction), cataracts, glaucoma and retinal disorders. Product
innovations range from basic systems such as slit lamps and fundus cameras
to standard setting diagnostic systems such as the Humphrey® Field
Analyzer, the Stratus OCT™ and the IOLMaster®, through to the surgical
microscopes and innovative treatment systems in refractive laser surgery.
In the field of neuro and ENT surgery, Carl Zeiss Meditec is the world's
leading provider of surgical microscopes and microsurgical visualisation
solutions for a very broad range of applications, such as tumour and
vascular surgery in the head region and/or spinal surgery. The most recent
example of our innovative performance in the area of microsurgery is the
OPMI Pentero® visualization system, which allows efficient and ergonomic
patient treatment.
Carl Zeiss Meditec's medical technology portfolio is rounded off by
visualization systems for doctors in private practice and promising future
technologies such as intraoperative radiation therapy, which allows the
targeted treatment of breast cancer and brain cancer directly during
surgery.
Carl Zeiss Meditec AG is based in Jena, Germany, with subsidiaries in
Germany (Carl Zeiss Meditec Surgical GmbH and Carl Zeiss Meditec
Vertriebsgesellschaf mbH), the USA (Carl Zeiss Meditec, Inc., Dublin,
California), in Japan (Carl Zeiss Meditec Co., Ltd., Tokyo), Spain (Carl
Zeiss Meditec Iberia S.A., Madrid) and France (Ioltech SAS, La Rochelle,
and Carl Zeiss Meditec France SAS, Le Pecq).
Thirty-five percent of the Carl Zeiss Meditec shares are in free float. The
remaining 65 percent are held by Carl Zeiss, one of the world's leading
international groups engaged in the optical and opto-electronics industry.
For additional information, visit www.meditec.zeiss.com/usa.